Anesthetic Choice/Management Long Term Consequences
Mar 29, 2015
Anesthetic Choice/Management
Long Term Consequences
GoalsPerioperative management implications for cancer patients
PeriOperative Morbidity & Mortality
1980’s Anesth mortality was 1:10,000 now this is closer to 1:100,000
Δ Mandated SpO2, ETCO2, NIBP,ECG and AAM technology
10% all cause mortality (age 65+) in the year after surgery is 10,000 X more common than preventable anesthetic deaths but ......
Increasing evidence suggests PeriOp management may have long term consequences – PO Neuro Cognitive , Surg Site Infection and Cancer Recurrance
“Recent” Anesthetic Management History
90’s periOp B blockers reduce all cause mortality @ 1 year ( Swedish study with Atenolol)
NA studies had more aggressive end pts and there was a significant increase in PeriOp strokes
Spinals/epidurals (pelvic,urologic,major ortho) blood loss , DVTs, chronic incisional pain and PONCD
More History
Terri Monk – BIS monitor observational study reported a 3 fold increase in one year mortality in elderly patients with deep anesthesia. This has now spawned the “B Aware” trials. She also noted;
More pronounced effects of anesthetic agents in patients with carcinoma and commented on;
Significant adverse long term consequence to GA esp at the extremes of age
Learning & behavioural issues ≤ 2 years (possibly
age three in most recent studies) Neurocognitive decline - elderly
One of Monk’s conclusions
“We must investigate the mechanisms by which patients with cancer respond to standard anesthetic doses with more pronounced cortical electrical depression and how pharmacokinectics and dynamics are altered in pre existing disease states”
Pharmacologic Implications – foranother time
IARS Smart Tots® research initiatives on pediatric inhalational anesthesia - (neuroplasicity, agent toxicity vs stress) i.e. This is more than separation anxiety!
Ketamine ( nmda receptor inhibitors) Illicit substances ( Ecstasy,
Amphetamines, Cocaine, crystal meth ......)
Etomidate
Are Anesth & Surg during infancy associated with altered academic performance during childhood?*
Ca Surgery : Generalizations from the lab
Surgical manipulation – tumor cell release into lymphatics and blood stream
Micro metastases already present prior to surgery
This MINIMAL RESIDUAL DISEASE can result in clinical mets when there is a balance shift between the patient’s immune status and the tumors’ ability to seed,proliferate and attract new blood vessels
PeriOp balance shift * Surgery per se
Tumor cells released into circulation cell mediated immunity ( T cell
and NK cell function) Increased Vascular Endothelial and
other growth factors ( Normally promote wound healing but are pre empted by malignant cells)
PeriOp balance Shift* Volatile inhalational anesthetics
Dose/patient specific dependent depression of neutrophil, macrophage, dendritic cell, T cell and NK cell immune functions
PeriOp Balance Shift* Opiods
Morphine, and to a lesser degree synthetic narcotics, decrease cellular and humoral immune function. Systemic administration has been associated with a proangiogenic action promoting tumor growth.
By contrast most non opiod analgesia preserves NK cell function and, in rodents, reduces metastatic tumor spread.
MOR – Opiod Receptor
Red – single nucleotide polymorphisms
Neoplastic Variability
MOR – u opiod receptor
VEGF – vasc endo growth factor
Various mammallian tumor cell lines result in enhanced specificity of the mediators of angiogenisis
Opiod Receptor Gene A118G polymorphism predicts survival in patients with breast cancerBortstov AV et al Anesthesiology April 2012 896-902
Genotype stratification was correlated to breast cancer specific mortality
One further observation re European American vs Afro American breast cancer survival data
Regional Anesthesia;Spinals & Epidurals
Prevent Neuroendocrine Stress by;1. Blocking afferent neural traffic2. Blocking descending efferent activation
of the sympathetic nervous system
Note: narcotic doses required to generate a stress free surgical anesthetic are impractical in most instances.
? Regional – General Combo
If pre incision functioning block then Neuroendocrine stress
volatile anesthetic requirements post op opiods endogenous opiods (endorphins)
Caveat: adequate perfusion pressure
“Random”, but associated studies
Paravertable blocks; 4 fold in recurrence or mets in breast Ca
Primary melanoma excision; if GA vs local or regional anesthesia: -ve predictive value 1.46 for survival
Epidural anesthesia for Radical Prostatectomy, colonic cancer surgery and Ovarian Serous Adenocarcinoma – variable but survival or “cancer free” period
Other PeriOp decisions
Blood transfusionGlucose controlFluid managementInhalational anesthetic toxicity –
newbornsPersistent incisional painBeta blockerscentral ᾄ agonists – clonidineNSAIDS NMDA receptor blockers
Long term survival after colon cancer surgery:A variation associated with the choice of anesthesia Christopherson R et al Anesth Analg 2008:107;325-32
A subset of the CSP #345 ; the effect of Epidural Anesthesia/analgesia on perioperative outcome
Prospective, randomized Aortic,gastric,biliary and colonic surgery
Mar 92 to August 94 – followup to Dec 2002
Epidural .5% bupivacaine, Epi 1:200,000 : T6 block prior to GA
End pts; ,MI,CHF,HB,BP,PE,Resp failure,cerebral insults,ARF : were all NS at 30 days
Post op pain, ambulation, LOS
#345 (n=1021) Colonic Ca sub group
247 pts with complete followup of 177
also of note: 70 not in study had similar survival experience
92 GA, 85 EGA IV post op opiods or 48+ hours
epidural analgesiaGA: Isoforane,
N2O,Vecuronium,fentanyl
Long term survival Colonic CaChristopherson R et al Anesth Analg 2008Median survival: mets 2 yrs, no mets 6.1 yrs
Long Term Survival colonic CaChristopherson R et al Anesth Analg 2008
Epidural vs Traditional Pain Mgmt – Survival & Ca recurrance after Colectomy . Cummings KC etal Anesthesiology April 2012: 797- 805N=42151 with 23% epidural during
resection1996-2005, > 65 years with 4 year
follow up minimum> 1 year increase all cause survival
in epidural groupNo change in cancer reccurance rate
Anesthetic Technique for Radical Prostatectomy Surgery Affects Cancer Recurrance – Retrospective Analysis Biki B et al Anesthesiology 2008: 109; 180-7
Patients for RP Jan 94- Dec 03 f/u to Oct 06
GA; fentanyl 1-2 ug/kg, propofol 1-2mg/kg,.5mg/kg atracurium N2O/O2, Diclofenac 75-100 bid
T11-12 epidural Rx prior to surgery vs post op IV PCA
If Epidural patients required post op IV morphine they were included in the GA group n=6
Anesthetic Technique for Radical Prostatectomy Surgery Affects Cancer Recurrance – Retrospective Analysis Biki B et al Anesthesiology 2008: 109; 180-7 ......cont
GA/PCA =123, Epidural/GA =102 : #s in each group determined by preferences, relative contraindications etc
was NS but ASA score,complications & surg time in epidural group
Primary outcome “biochemical recurrence” ie
PSA from post op nadir possible Rad Rx, endocrine or chemo Rx
Radical Prostate, lymph node dissection
Potential Influence of the Anesthetic Technique used during Open Radical Prostatectomy on Prostate Cancer related Outcome Wuethrich PY et al Anesth 2010:113;570-6
retrospective study Jan94-June97 n=103 GA+TEA, 45 not
incl re inadequate TEA July97-Dec2000 n=158 GA+
Morphine/Ketoloric Primary OutcomesBiochemical recurrence free survivalClinical progression free survivalCancer specific survivalOver all survival
Potential Influence Rad ProstateWuethrich et al Anesthiology 2010
Standardized GA incl fentanyl 2 ug/kg, N2O,forane
T10-12 TEA .25% bupivacaine 8-10 cc/hr, No COX inhib
PostOp .1% bupivacaine/fentanyl 2ug/cc @ 8-15 cc/hr X 48 hrs
Limitations TEA group – higher ASA, 2X infusion rate and less fentanyl (confounding variables)
Potential Influence Rad ProstateWuethrich et al Anesthiology 2010
Potential Influence Rad ProstateWuethrich et al Anesthiology 2010 Disscussion
Excess prostaglandin release and endogenous cortisol immunosuppression
NSAIDS inhibit prostaglandin synthesis
Cyclooxyngenase 2 is induced in “tumor promoters” – prostaglandin synthesis increase prostate cell lines while COX2 inhibitors induce apoptosis (cell death)
Do Intraoperative Analgesics Influence Breast Cancer Recurrence after Mastectomy? A retrospective analysisAnesth Analg 2010: 110; 1630-5
327 mastectomy/Axillary dissection chart reviews – 1 surgeon, 1 Oncologist, 2 anesthetists ( Feb ‘03- Sept ‘08)
8 excluded re pulm mets, incomplete op etc.
Pre incision: Clonidine or Ketamine or Ketoloric, all received postOp diclofenac & acetaminophen
GA sufentanil, STP or propofol, Sevo or Des plus Air/Oxygen
Breast Ca recurrance / Ketalorac
The Effects of Anesthetic Technique on Cancer Recurence ---RFA Small Hepatocellular CarcinomaLai A et all A&A 2012; 114: 290-6
Retrospective review Aug 1999 – Dec 2009 ; 179 consecutive pts with < 3cm hepatic tumors
End points - overall and recurrence free survival
Epidural (T8-10 1.5% lidocaine) vs GA (Fentanyl, Propofol TIVA)
Study limitation – adequate epidural anesthesia was not defined
Study results ???
????
RFA Hepatocellular Ca ......Hazard ratios:
Recurrance free survival; Epi vs GA (3.66), Tumor # (2.28), GGT ( 1.39)
Overall survival; Liver function (2.30), Tumor # (2.36) GA no benefit in overall survival
Inverse probability weighted Epi vs GA = 1.26Epidural anesthesia for this procedure can be
associated with referred pain requiring add’n opiods. This could also limit current intensity or duration of therapy. Epi patients did not have any opiod sparing in the post op period.
SpA vs GA for lower limb MMBR J Anaesth June 15 2012
Mortality during a 10 yr Obs study52 SpA vs 221 GATrend toward better Cumulative
survival rates in patients who received spinal anesthesia:
SpA 96 months (CI 81-111)GA 69 months (CI 50-88)
SummaryWhat do we know about surgical stress response and Cancer?
A mine field – Periop period Opiods – analogs
of morphine – u3 Cox inhibiters Alpha adrenergic
antagonists Beta blockers Inhalational
anesthetics Regional
anesthesia
TRIM ( transfusion related immunomodulation)
Hypothermia Sepsis Statins Etomidate
Are GA’s always bad for Ca recurrance?The answer is : IT DEPENDENDS
Volatile Anesthetics Reduce Invasion of Colorectal Cancer cells thru down regulation of matrix metalloproteinase -9Muller Edenborn et al Anesthesiology 2012 117: 293-301
Malignant tumors invade extracellular matrix
Surgical clamping triggers a reperfusion injury by upregulation of MMP9 (neutrophils,a rich source of MMP9, accumulate because of IL 8)
Complex in vitro study demonstrated volatile anesthetics reduce reperfusion injury – this is not new
But indices of colorectal matrix invasion were reduced
Conclusion
Data suggests;the possibility that anesthetic conduct may contribute to the recurrence of cancer ( liberal opiod Rx or inadequate analgesia)
Equally worrying is the possibility that anesthesia, or the stress response to surgery could activate dormant cancer cells in an individual undergoing non cancer surgery.